Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Asenapine Sublingual Tablets, 5 mg and 10 mg.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Asenapine Sublingual Tablets, 5 mg and 10 mg.".